
Indian Nationals Charged With Smuggling Counterfeit Ozempic Into U.S.
The story in brief
Two Indian nationals, Swapandip Roy and Vicky Ramancha, were charged with smuggling counterfeit Ozempic into the U.S., despite FDA seizures in December 2023. The scheme, which continued until April 2024, involved fake packaging and labels to mimic authentic products, allegedly obtained from unauthorised sources in China. Roy, extradited from Italy, faced up to 71 years in prison.